- Home
- SVRA vs VRE Comparison
SVRA vs VRE Comparison
Compare SVRA & VRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SVRA | VRE |
|---|---|---|
| Founded | 2007 | 1949 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | N/A | 1994 |
Fundamental Metrics
Financial Performance| Metric | SVRA | VRE |
|---|---|---|
| Price | $5.83 | $14.76 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 4 |
| Target Price | $6.88 | ★ $18.25 |
| AVG Volume (30 Days) | ★ 2.2M | 637.3K |
| Earning Date | 11-12-2025 | 10-22-2025 |
| Dividend Yield | N/A | ★ 2.16% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.68 |
| Revenue | N/A | ★ $291,348,000.00 |
| Revenue This Year | N/A | $6.48 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $23.56 |
| Revenue Growth | N/A | ★ 6.39 |
| 52 Week Low | $1.89 | $13.69 |
| 52 Week High | $6.37 | $18.29 |
Technical Indicators
Market Signals| Indicator | SVRA | VRE |
|---|---|---|
| Relative Strength Index (RSI) | 74.17 | 47.66 |
| Support Level | $5.09 | $14.88 |
| Resistance Level | $6.37 | $15.18 |
| Average True Range (ATR) | 0.39 | 0.29 |
| MACD | 0.15 | -0.02 |
| Stochastic Oscillator | 82.26 | 16.46 |
Price Performance
Historical ComparisonAbout SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.
About VRE Veris Residential Inc.
Veris Residential Inc is a fully-integrated, self-administered and self-managed real estate investment trust (REIT). The company owns and operates a real estate portfolio comprised predominantly of multifamily rental properties located mainly in the Northeast and Class A office properties. The company performs substantially all real estate management, leasing, acquisition and development on an in-house basis. The properties are in three states in the Northeast, plus the District of Columbia. The company operates in two industry segments multifamily real estate & services and commercial & other real estate. The majority of revenue is from Multifamily real estate services.